L.P. Zanaga

Is Isoniazid Safe for Liver Transplant Candidates With Latent Tuberculosis?

R.S.B. Stucchi, Ilka de Fátima Santana Ferreira Boin, Rodrigo Nogueira Angerami et al. · Transplantation Proceedings · 2012 · 27 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response

N. Miotto, L.C. Mendes, L.P. Zanaga et al. · PLoS ONE · 2018 · 25 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C

L.C. Mendes, Paulo Roberto Abrão Ferreira, N. Miotto et al. · Brazilian Journal of Medical and Biological Research · 2016 · 19 citations · Full text

Medicine, Internal Medicine, Pathology +17

Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

N. Miotto, L.C. Mendes, L.P. Zanaga et al. · Brazilian Journal of Medical and Biological Research · 2016 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis: results of a real-life cohort

N. Miotto, L.C. Mendes, L.P. Zanaga et al. · European Journal of Gastroenterology & Hepatology · 2017 · 10 citations

Pharmacy, Internal Medicine, Pharmacotherapy +17